J&J Expects Oncology Sales of USD 50B by 2030: Can It Achieve the Goal? — Neutral
JNJ Zacks Investment Research — July 18, 2025JNJ eyes $50B in oncology sales by 2030, driven by drugs like Darzalex, Erleada, new launches including Carvykti and Tecvayli, and its cancer pipeline.
Oppenheimer's Jason Helfstein gives his read on Netflix's outlook post q2 earnings beat — Positive
NFLX CNBC Television — July 18, 2025Jason Helfstein, Oppenheimer senior internet analyst, joins 'Money Movers' to discuss his takeaways from Netflix's q2 earnings.
LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action.
Comerica Q2 Earnings Top Estimates on Strength in NII & Loan Growth — Positive
CMA Zacks Investment Research — July 18, 2025CMA tops Q2 earnings estimates as NII jumps nearly 8% and loan balances climb, despite asset quality concerns.
American Express sees record member spending. Here's what we know — Positive
AXP CNBC Television — July 18, 2025CNBC's Hugh Son joins 'Money Movers' to discuss takeaways from American Express' earnings call.
Strength Seen in StepStone Group (STEP): Can Its 6.0% Jump Turn into More Strength? — Positive
STEP Zacks Investment Research — July 18, 2025StepStone Group (STEP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Markets Await Consumer Sentiment Reading — Neutral
AXP MMM SCHW Zacks Investment Research — July 18, 2025Pre-market futures are up again as a very eventful trading week winds to a close. The Dow is currently +0.12%, the S&P 500 is +0.09% and the Nasdaq +0.16% at this hour.
Regions Financial: Tech Investments Drove 10% YOY Revenue Growth — Positive
RF PYMNTS — July 18, 2025Regions Financial Corp.'s investments in technology and talent drove 10% year-over-year growth in revenue in the second quarter, bringing the regional bank's total revenue for the quarter to $1.9 billion, according to a Friday (July 18) earnings release.
Sarepta shares sink on 3rd patient death amid restructuring statement — Negative
SRPT CNBC Television — July 18, 2025CNBC's Angelica Peebles joins 'Squawk on the Street' with the latest news on Sarepta following a patient death.
F.N.B. Corporation (FNB) Q2 2025 Earnings Call Transcript — Neutral
FNB Seeking Alpha — July 18, 2025F.N.B. Corporation (NYSE:FNB ) Q2 2025 Earnings Conference Call July 18, 2025 8:30 AM ET Company Participants Christopher Chan - Executive VP & Chief Strategy Officer of First National Bank of Pennsylvania Gary Lee Guerrieri - Chief Credit Officer Lisa Hajdu - Corporate Participant Vincent J. Calabrese - Chief Financial Officer Vincent J.
Charles Schwab CEO: Advisor and retail channels are both sources of growth — Positive
SCHW CNBC Television — July 18, 2025Rick Wurster, Charles Schwab CEO, joins 'Money Movers' to discuss the company's earnings, what's contributing to growth and the impact of crypto.
Fed governor Waller pushes for rate cut, Chevron completes Hess acquisition — Positive
CVX HES Yahoo Finance — July 18, 2025Here is what you may have missed on Morning Brief on Friday, July 18. Federal Reserve governor Christopher Waller says he would like to see the central bank cut rates at its July meeting, putting him in conflict with other FOMC members who want to wait on cuts.
Iovance: I'm Switching From Sell To Buy Despite Likely Approval For Rival Drug — Neutral
IOVA Seeking Alpha — July 18, 2025Iovance Biotherapeutics, Inc. stock is down nearly 30% since my "sell" recommendation in April. Q1 earnings disappointed, with Amtagvi sales underperforming the Street's expectations and guidance revised downward. The impending approval of a rival therapy in the advanced melanoma space - Replimmune's RP1 - is another cause for concern.
QQQI ETF: I See Better Hiding Places Amid Record NASDAQ Levels — Positive
QQQI Seeking Alpha — July 18, 2025QQQI piqued my interest as rising NASDAQ valuations make covered-call funds attractive. But I see better alternatives such as QYLD and JEPQ. Compared to these funds, QQQI has higher fees and lower liquidity.
KLA Stock, Quanta Form This Chart Pattern, Giving The Green Light To Buy — Neutral
KLAC Investors Business Daily — July 18, 2025KLA stock and Quanta Services both flashed new buy points after big moves higher.
ETFs to Capitalize on TSM's Impressive Q2 Earnings — Positive
TSM Zacks Investment Research — July 18, 2025TSM's blowout Q2 performance fuels gains for ETFs like SPWO, SPTE, SMH, MEMX, and EMM, all heavily exposed to the AI chip leader.
Webster Financial Tops Q2 Earnings on Higher Fee Income, Stock Gains — Positive
WBS Zacks Investment Research — July 18, 2025WBS stock climbs after Q2 earnings top forecasts, fueled by rising fee income, NII and improved profitability.
Paul Sankey gives his read on Chevron's acquisition of Hess — Neutral
CVX HES CNBC Television — July 18, 2025Paul Sankey, Sankey Research lead analyst, joins 'Money Movers' to discuss Chevron closing on the Hess acquisition and what it means for the company and on the oil sector.
Sprouts Farmers Market: Shares Offer Little To No Upside — Positive
SFM Seeking Alpha — July 18, 2025Sprouts Farmers Market is delivering impressive growth in revenue, profitability, and store count, with strong digital and private label expansion. Despite robust fundamentals and a net cash position, I view shares as expensive both absolutely and relative to peers, limiting upside. Management's aggressive growth plans and loyalty initiatives are promising, but valuation remains a concern even with optimistic guidance.
